StockData
Mangoceuticals, Inc. logo

Mangoceuticals, Inc. (MGRX) stock

MGRXNasdaqServices-Misc Health & Allied Services, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 7/30
$0.15−0.03 (-16.22%)

Close on Nov 13, 2026Market cap $3.34MP/E –Yield –

Mangoceuticals enterprise value

Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.

Mangoceuticals's enterprise value was $3.36M on Nov 11, 2026, against $14.93M a year earlier. Over the last 4 years it ranged from $3.36M to $28.03M, with a median of $7.16M.

Enterprise Value at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$3.36M-65.7%
2025Dec 31, 2025$9.79M+92.3%
2024Dec 31, 2024$5.09M+49.2%
2023Dec 29, 2023$3.41M–

More Mangoceuticals figures

See a number that looks wrong?